Evaluation of Pan-Immune-Inflammation Value (PIV) as a Predictive Biomarker for Psoriatic Arthritis in Patients with Psoriasis.

High PIV was more frequently observed in younger patients, females, individuals with the vulgaris subtype, those with widespread skin lesions, those without nail involvement, those without comorbidities, those receiving systemic therapy, and patients with longer disease durations; however, these associations did not reach statistical significance (p>0.05).

also in 111,027 other papers